SCHEMBL24519042

SCHEMBL24519042

c1ccc2c(c1)oc1ccc3oc4cc(-c5c6ccccc6c(-c6ccc7oc8ccc9oc%10ccccc%10c9c8c7c6)c6ccccc56)ccc4c3c12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AHR P35869 3/20 0.44
▸ MAPT P10636 4/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ KDM4E B2RXH2 3/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ HPGD P15428 3/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ HCRTR1 O43613 1/20 0.40
▸ MAOA P21397 4/20 0.40
▸ PLA2G2A P14555 3/20 0.39
▸ PLA2G4A P47712 3/20 0.39
▸ GLA P06280 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ PGAM1 P18669 1/20 0.38
▸ CASP1 P29466 1/20 0.38
▸ CASP7 P55210 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24518935 0.98 AHR (0.47) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL24519043 0.96 AHR (0.47) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL24518927 0.95 MAPT (0.47) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL17944902 0.95 AHR (0.50) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL24518913 0.95 HPGD (0.44) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL26492196 0.93 MAPT (0.41) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL17945501 0.92 AHR (0.43) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL17944857 0.91 MAPT (0.50) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL19109887 0.90 MAPT (0.46) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL17944558 0.90 PLA2G2A (0.43) AHRMAPTMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11367838-B2 Anthracene derivative and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2022-06-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11367838-B2 Anthracene derivative and organic light-emitting device comprising same CCNL2, CRY1, CYP2S1 AHR 18/4885MAPT 4193/4885MEN1 783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback